Ispire Technology

ISPR · NASDAQ

$1.36−$0.06 (−4.23%)TodayMarket closed · Oct 20, 4:10 PM ET

Prev close $1.42

ISPR analyst rating

This isn't available right now. Refresh to try again.

The case for and against

Updated Oct 31, 2025

Bull case

Ispire Technology Inc. has demonstrated a robust financial performance, with revenue reaching $15.4 million, representing approximately a 30% year-over-year increase, primarily driven by strategic investments in its Malaysian facility and the submission of PMTA applications. The ongoing demand for the company’s e-cigarettes and cannabis vaping products is critical for sustaining growth and positive free cash flow. Additionally, regulatory developments, such as the FDA's recent focus on illicit vape shipments, may enhance market conditions in the U.S. and present new opportunities for Ispire's product offerings.

Bear case

Ispire Technology Inc. reported a significant decrease in revenue, with 2Q'25 figures of $26.2 million showing a decline of approximately 13% year-over-year and a stark 37% quarter-over-quarter drop, highlighting a troubling trend in sales performance. The company also faced a net income loss of $10.9 million, reflecting a continued negative financial trajectory compared to the previous year. Additionally, a gross margin (GM%) of 18.2%, alongside challenges such as tariff impacts and seasonality, indicates pressure on profitability that further compounds the company’s financial difficulties.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.